These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24471727)

  • 1. Comment on: New-onset diabetes and impaired fasting glucose after a liver transplant: risk analysis and the effect of tacrolimus dosage.
    Kabir A
    Exp Clin Transplant; 2014 Feb; 12(1):85. PubMed ID: 24471727
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to: Comment on: New-onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose.
    Lankarani KB; Nikeghbalian S; Janghorban P; Malek-Hosseini SA
    Exp Clin Transplant; 2014 Feb; 12(1):86. PubMed ID: 24471728
    [No Abstract]   [Full Text] [Related]  

  • 3. New onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose.
    Lankarani KB; Eshraghian A; Nikeghbalian S; Janghorban P; Malek-Hosseini SA
    Exp Clin Transplant; 2014 Feb; 12(1):46-51. PubMed ID: 23902591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of tacrolimus-induced diabetes in rat model and assessment of clinical treatments for post-transplant diabetes mellitus in liver transplant recipients.
    Niu YJ; Shen ZY; Xu C; Li CF; Liu XJ; Teng YQ; Chen H; Li L; Cheng HM; Yang XM; Mao S
    Clin Lab; 2013; 59(7-8):869-74. PubMed ID: 24133918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects of the calcineurin inhibitor, such as new-onset diabetes after kidney transplantation.
    Borda B; Lengyel C; Várkonyi T; Kemény E; Ottlakán A; Kubik A; Keresztes C; Lázár G
    Acta Physiol Hung; 2014 Sep; 101(3):388-94. PubMed ID: 25183511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis.
    Li DW; Lu TF; Hua XW; Dai HJ; Cui XL; Zhang JJ; Xia Q
    World J Gastroenterol; 2015 May; 21(20):6329-40. PubMed ID: 26034369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
    Batista F; Auyanet I; Torregrosa JV; Oppenheimer F
    Transplant Proc; 2012 Nov; 44(9):2582-4. PubMed ID: 23146461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors Associated With New-Onset Diabetes After Liver Transplant: A Case Control Study.
    Terto SV; Araújo ST; Negreiros FDDS; Brasil BMBL; da Cunha GH; Rodrigues AB; de Carvalho MMD; Gadelha DD; Carioca AAF; Oliveira Fernandes V; Montenegro Júnior RM
    Transplant Proc; 2019; 51(6):1956-1961. PubMed ID: 31303408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of new-onset diabetes mellitus after conversion from tacrolimus to cyclosporine in liver transplant patients: results of a pilot study.
    Lorho R; Hardwigsen J; Dumortier J; Pageaux GP; Durand F; Bizollon T; Blanc AS; Di Giambattista F; Duvoux C
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):482-8. PubMed ID: 21530445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset diabetes after transplantation: drug-related risk factors.
    Santos L; Rodrigo E; Piñera C; Quintella E; Ruiz JC; Fernández-Fresnedo G; Palomar R; Gómez-Alamillo C; de Francisco A; Arias M
    Transplant Proc; 2012 Nov; 44(9):2585-7. PubMed ID: 23146462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience.
    Xu X; Ling Q; He ZL; Gao F; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):465-70. PubMed ID: 18842490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression.
    Khoury N; Kriaa F; Hiesse C; Von Ey F; Durbach A; Ammor M; Hafi A; Djeffal R; Boubenider S; Droupy S; Hammoudi Y; Eschwege P; Benoît G; Charpentier B
    Transplant Proc; 2000 Dec; 32(8):2763-4. PubMed ID: 11134791
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.
    Chen QJ; Li J; Zuo SR; Zhang YP; Jia SJ; Yuan H; Liu SK; Cheng K; Ming YZ; Zuo XC; Luo AJ; Xie WZ; Cai JJ; Yang M; Wang JL
    Ren Fail; 2015 May; 37(4):601-6. PubMed ID: 25644968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating mechanisms of post-transplant diabetes mellitus.
    van Hooff JP; Christiaans MH; van Duijnhoven EM
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi8-vi12. PubMed ID: 15575024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients.
    Shi D; Xie T; Deng J; Niu P; Wu W
    Eur J Clin Pharmacol; 2018 Jun; 74(6):723-729. PubMed ID: 29546446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients.
    Sánchez-Pérez B; Aranda Narváez JM; Santoyo Santoyo J; Fernández-Aguilar JL; Suárez Muñoz MA; González-Sánchez AJ; Pérez Daga JA; Ramírez Plaza CP; Carrasco Campos J; Jiménez Mazure C; Becerra Ortíz R
    Transplant Proc; 2008 Nov; 40(9):2994-6. PubMed ID: 19010171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus after living donor liver transplantation: data from mainland China.
    Zhao J; Yan L; Li B; Zeng Y; Wen T; Zhao J; Wang W; Xu M; Yang J; Ma Y; Chen Z; Wu H; Wei Y
    Transplant Proc; 2009 Jun; 41(5):1756-60. PubMed ID: 19545722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
    Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
    Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy.
    Varo E; Padin E; Otero E; Tomé S; Castroagudin JF; Delgado M; Conde R; Segade FR; Mella C; González-Quintela A
    Transplant Proc; 2002 Aug; 34(5):1553-4. PubMed ID: 12176481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.